Spandow Oliver J. 4
4 · NEPHROS INC · Filed Nov 26, 2019
Insider Transaction Report
Form 4
NEPHROS INCNEPH
Spandow Oliver J.
Director
Transactions
- Purchase
Common Stock
2019-11-25$8.17/sh+1,000$8,170→ 10,786 total
Holdings
- 9,466
Stock Option (Right to Buy)
Exercise: $5.58Exp: 2028-08-10→ Common Stock (9,466 underlying) - 5,161
Stock Option (Right to Buy)
Exercise: $5.85Exp: 2028-12-19→ Common Stock (5,161 underlying)
Footnotes (3)
- [F1]The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.079 to $8.50. The reporting person undertakes to provide Nephros, Inc., any security holder of Nephros, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]The option vests as to 3,156 shares on 8/10/19 and as to 3,155 shares on each of 8/10/20 and 8/10/21.
- [F3]The option vests as to 1,721 shares on 12/19/18 and as to 1,720 shares on each of 12/19/19 and 12/19/20.